102 results
8-K
EX-10.1
VIRX
Viracta Therapeutics Inc
20 Mar 24
Departure of Directors or Certain Officers
4:42pm
executives of the Company, including, without limitation, the Company’s 401(k) retirement plan, group medical, dental, vision, disability, life insurance … employment with the Company outside of the Change in Control Period (as defined below) other than for Cause (as defined below), death or Disability
8-K
VIRX
Viracta Therapeutics Inc
20 Mar 24
Departure of Directors or Certain Officers
4:42pm
Ms. Burcar’s employment other than for “cause,” death or “disability” or Ms. Burcar resigns for “good reason” outside the period beginning three (3 … immediately prior to termination.
If the Company terminates Ms. Burcar’s employment other than for cause, death or disability, or Ms. Burcar resigns
8-K/A
EX-10.1
VIRX
Viracta Therapeutics Inc
5 May 23
Departure of Directors or Certain Officers
4:52pm
is an independent Consultant, Company will not withhold or make payments for social security; make unemployment insurance or disability insurance contributions … state and federal laws governing self-employed individuals, including obligations such as payment of taxes, social security, disability and other
8-K
zf8qv4l0 0posgl2y
19 Sep 22
Viracta Therapeutics’ Board of Directors appoints Mark Rothera as President and Chief Executive Officer
8:10am
8-K
EX-10.2
97f0bp13ju7r
19 Sep 22
Viracta Therapeutics’ Board of Directors appoints Mark Rothera as President and Chief Executive Officer
8:10am
8-K
EX-10.1
aicikfms roo6a
19 Sep 22
Viracta Therapeutics’ Board of Directors appoints Mark Rothera as President and Chief Executive Officer
8:10am
8-K
d8i 0yewz0m3w07rx33o
24 Feb 21
Viracta Therapeutics Announces Closing of Merger with Sunesis Pharmaceuticals and $65M Private Placement
4:34pm
424B3
m4pn5myfp7cqfx5
14 Jan 21
Prospectus supplement
5:11pm
S-4/A
EX-10.19
009l1szv
12 Jan 21
Registration of securities issued in business combination transactions (amended)
9:54pm